{
    "nct_id": "NCT03631017",
    "official_title": "Safety, Biodistribution and Radiation Dosimetry of [18F]PARPi",
    "inclusion_criteria": "Part 1:\n\n* Age ≥18 years\n* ECOG performance status 0 or 1\n* Biopsy (histologically or cytologically) proven Squamos Cell Carcinoma\n* Oral cavity, oropharynx, or nasopharynx primary site\n* At least one tumor lesion on standard of care imaging with a minimum diameter of at least 1.5 cm\n* Scheduled to undergo treatment at MSKCC\n* Willingness to sign informed consent\n\nPart 2\n\n* Age ≥18 years\n* ECOG performance status 0 or 1\n* Biopsy (histologically or cytologically) proven Squamous Cell Carcinoma\n* Oral cavity,oropharynx, or nasopharynx primary site\n* Scheduled to undergo surgery (neck dissection and/ or neck dissection + surgical removal of the primary) at MSK\n* Willingness to sign informed consent\n* Should have had a standard-of-care [18F]-FDG PET/CT scan before surgery (to minimize the possibility of new alterations developing between the two scans both scans should be acquired within a maximum time difference of one month).\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Significantly impaired organ function that may interfere with the excretion and metabolism of the imaging agent. Specifically, patients will be excluded if they meet the following criteria:\n* Hematologic\n\n  o Platelets <75K/mcL\n* Hepatic\n\n  * Bilirubin >2.0 x ULN (institutional upper limits of normal)\n  * AST/ALT >2.5 x ULN\n* Renal\n\n  o Creatinine > 2.0 x ULN\n* Claustrophobia interfering with PET/CT imaging\n\n  * Known allergy to PEG300\n  * Pregnancy or breastfeeding",
    "miscellaneous_criteria": ""
}